skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: assunto: Lung Neoplasms - Drug Therapy remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

Horn, Leora ; Mansfield, Aaron S ; Szczęsna, Aleksandra ; Havel, Libor ; Krzakowski, Maciej ; Hochmair, Maximilian J ; Huemer, Florian ; Losonczy, György ; Johnson, Melissa L ; Nishio, Makoto ; Reck, Martin ; Mok, Tony ; Lam, Sivuonthanh ; Shames, David S ; Liu, Juan ; Ding, Beiying ; Lopez-Chavez, Ariel ; Kabbinavar, Fairooz ; Lin, Wei ; Sandler, Alan ; Liu, Stephen V

The New England journal of medicine, 2018-12, Vol.379 (23), p.2220-2229 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
2
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

Gandhi, Leena ; Rodríguez-Abreu, Delvys ; Gadgeel, Shirish ; Esteban, Emilio ; Felip, Enriqueta ; De Angelis, Flávia ; Domine, Manuel ; Clingan, Philip ; Hochmair, Maximilian J ; Powell, Steven F ; Cheng, Susanna Y.-S ; Bischoff, Helge G ; Peled, Nir ; Grossi, Francesco ; Jennens, Ross R ; Reck, Martin ; Hui, Rina ; Garon, Edward B ; Boyer, Michael ; Rubio-Viqueira, Belén ; Novello, Silvia ; Kurata, Takayasu ; Gray, Jhanelle E ; Vida, John ; Wei, Ziwen ; Yang, Jing ; Raftopoulos, Harry ; Pietanza, M. Catherine ; Garassino, Marina C

The New England journal of medicine, 2018-05, Vol.378 (22), p.2078-2092 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
3
Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331
Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331
Material Type:
Artigo 		Adicionar ao Meu Espaço

Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331

Spigel, D.R. ; Vicente, D. ; Ciuleanu, T.E. ; Gettinger, S. ; Peters, S. ; Horn, L. ; Audigier-Valette, C. ; Pardo Aranda, N. ; Juan-Vidal, O. ; Cheng, Y. ; Zhang, H. ; Shi, M. ; Luft, A. ; Wolf, J. ; Antonia, S. ; Nakagawa, K. ; Fairchild, J. ; Baudelet, C. ; Pandya, D. ; Doshi, P. ; Chang, H. ; Reck, M.

Annals of oncology, 2021-05, Vol.32 (5), p.631-641 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
Material Type:
Artigo 		Adicionar ao Meu Espaço

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden

Hellmann, Matthew D ; Ciuleanu, Tudor-Eliade ; Pluzanski, Adam ; Lee, Jong Seok ; Otterson, Gregory A ; Audigier-Valette, Clarisse ; Minenza, Elisa ; Linardou, Helena ; Burgers, Sjaak ; Salman, Pamela ; Borghaei, Hossein ; Ramalingam, Suresh S ; Brahmer, Julie ; Reck, Martin ; O’Byrne, Kenneth J ; Geese, William J ; Green, George ; Chang, Han ; Szustakowski, Joseph ; Bhagavatheeswaran, Prabhu ; Healey, Diane ; Fu, Yali ; Nathan, Faith ; Paz-Ares, Luis

The New England journal of medicine, 2018-05, Vol.378 (22), p.2093-2104 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
5
Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

Spigel, David R ; Faivre-Finn, Corinne ; Gray, Jhanelle E ; Vicente, David ; Planchard, David ; Paz-Ares, Luis ; Vansteenkiste, Johan F ; Garassino, Marina C ; Hui, Rina ; Quantin, Xavier ; Rimner, Andreas ; Wu, Yi-Long ; Özgüroğlu, Mustafa ; Lee, Ki H ; Kato, Terufumi ; de Wit, Maike ; Kurata, Takayasu ; Reck, Martin ; Cho, Byoung C ; Senan, Suresh ; Naidoo, Jarushka ; Mann, Helen ; Newton, Michael ; Thiyagarajah, Piruntha ; Antonia, Scott J

Journal of clinical oncology, 2022-04, Vol.40 (12), p.1301-1311 [Periódico revisado por pares]

United States: Wolters Kluwer Health

Texto completo disponível

Citações Citado por
6
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Material Type:
Artigo 		Adicionar ao Meu Espaço

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

Antonia, Scott J ; Villegas, Augusto ; Daniel, Davey ; Vicente, David ; Murakami, Shuji ; Hui, Rina ; Kurata, Takayasu ; Chiappori, Alberto ; Lee, Ki H ; de Wit, Maike ; Cho, Byoung C ; Bourhaba, Maryam ; Quantin, Xavier ; Tokito, Takaaki ; Mekhail, Tarek ; Planchard, David ; Kim, Young-Chul ; Karapetis, Christos S ; Hiret, Sandrine ; Ostoros, Gyula ; Kubota, Kaoru ; Gray, Jhanelle E ; Paz-Ares, Luis ; de Castro Carpeño, Javier ; Faivre-Finn, Corinne ; Reck, Martin ; Vansteenkiste, Johan ; Spigel, David R ; Wadsworth, Catherine ; Melillo, Giovanni ; Taboada, Maria ; Dennis, Phillip A ; Özgüroğlu, Mustafa

The New England journal of medicine, 2018-12, Vol.379 (24), p.2342-2350 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
7
Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer
Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer

Gadgeel, Shirish ; Rodríguez-Abreu, Delvys ; Speranza, Giovanna ; Esteban, Emilio ; Felip, Enriqueta ; Dómine, Manuel ; Hui, Rina ; Hochmair, Maximilian J ; Clingan, Philip ; Powell, Steven F ; Cheng, Susanna Yee-Shan ; Bischoff, Helge G ; Peled, Nir ; Grossi, Francesco ; Jennens, Ross R ; Reck, Martin ; Garon, Edward B ; Novello, Silvia ; Rubio-Viqueira, Belén ; Boyer, Michael ; Kurata, Takayasu ; Gray, Jhanelle E ; Yang, Jing ; Bas, Tuba ; Pietanza, M Catherine ; Garassino, Marina C

Journal of clinical oncology, 2020-05, Vol.38 (14), p.1505-1517 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
8
Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189
Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189

Rodríguez-Abreu, D. ; Powell, S.F. ; Hochmair, M.J. ; Gadgeel, S. ; Esteban, E. ; Felip, E. ; Speranza, G. ; De Angelis, F. ; Dómine, M. ; Cheng, S.Y. ; Bischoff, H.G. ; Peled, N. ; Reck, M. ; Hui, R. ; Garon, E.B. ; Boyer, M. ; Kurata, T. ; Yang, J. ; Pietanza, M.C. ; Souza, F. ; Garassino, M.C.

Annals of oncology, 2021-07, Vol.32 (7), p.881-895 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

Reck, Martin ; Rodríguez-Abreu, Delvys ; Robinson, Andrew G ; Hui, Rina ; Csőszi, Tibor ; Fülöp, Andrea ; Gottfried, Maya ; Peled, Nir ; Tafreshi, Ali ; Cuffe, Sinead ; O’Brien, Mary ; Rao, Suman ; Hotta, Katsuyuki ; Leiby, Melanie A ; Lubiniecki, Gregory M ; Shentu, Yue ; Rangwala, Reshma ; Brahmer, Julie R

The New England journal of medicine, 2016-11, Vol.375 (19), p.1823-1833 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
10
Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer
Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer

Soria, J.-C. ; Mauguen, A. ; Reck, M. ; Sandler, A.B. ; Saijo, N. ; Johnson, D.H. ; Burcoveanu, D. ; Fukuoka, M. ; Besse, B. ; Pignon, J.-P.

Annals of oncology, 2013-01, Vol.24 (1), p.20-30 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2007  (5)
  2. 2007Até2010  (11)
  3. 2011Até2014  (12)
  4. 2015Até2019  (23)
  5. Após 2019  (17)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (67)
  2. Japonês  (9)
  3. Russo  (6)
  4. Alemão  (1)
  5. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.